Momentum: MACD histogram -0.0116 and negatively expanding → bearish momentum is still strengthening, not stabilizing.
RSI: RSI_6 = 19.83 (oversold) → conditions are ripe for a technical bounce, but oversold can stay oversold in strong downtrends.
Key levels: Price (~0.654 pre-market) is sitting on/just below S1 (0.655). If it fails to hold, next support is S2 (0.596). Overhead resistance starts near Pivot (0.75), then R1 (0.845).
Pattern-based forward odds provided: 50% chance of -0.31% next day, -1.31% next week, -2.1% next month → skew remains negative.
Overall: financial trend shows ongoing cash burn with no revenue growth support, which weighs on medium-term upside and increases financing risk.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided, so there is no clear evidence of improving Wall Street sentiment.
Practical “pros vs cons” view from available info:
Pros: clinical/pipeline optionality can create sharp rallies on positive updates.
Cons: delisting overhang + persistent losses + bearish technicals dominate near-term risk/reward, making the setup unattractive for a buy-right-now decision.
Wall Street analysts forecast GLMD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GLMD is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast GLMD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GLMD is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
